Show simple item record

dc.contributor.authorMucci, Samantha [UNIFESP]
dc.contributor.authorCitero, Vanessa de Albuquerque [UNIFESP]
dc.contributor.authorGonzalez, Adriano Miziara [UNIFESP]
dc.contributor.authorGeocze, Luciana [UNIFESP]
dc.contributor.authorGeocze, Stephan [UNIFESP]
dc.contributor.authorLopes Filho, Gaspar de Jesus [UNIFESP]
dc.contributor.authorDe Marco, Mario Alfredo [UNIFESP]
dc.contributor.authorParise, Edison Roberto [UNIFESP]
dc.contributor.authorNogueira Martins, Luiz Antonio [UNIFESP]
dc.date.accessioned2016-01-24T14:31:11Z
dc.date.available2016-01-24T14:31:11Z
dc.date.issued2013-02-01
dc.identifierhttp://dx.doi.org/10.1007/s11136-012-0138-2
dc.identifier.citationQuality of Life Research. Dordrecht: Springer, v. 22, n. 1, p. 167-172, 2013.
dc.identifier.issn0962-9343
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/35921
dc.description.abstractPurpose the aim of this study was to validate the Chronic Liver Disease Questionnaire (CLDQ) for use in Brazilian population.Method A total of 200 patients with chronic liver disease and varying disease severity answered a socio-demographic questionnaire, t CLDQ, and the Medical Outcome Study Short Form 36 (SF-36). Patients returned in 1-15 days to answer CLDQ again. the Cronbach's alpha of the total CLDQ score was 0.95 and fluctuated between 0.69 and 0.83 in its six domains.Results the intra-class correlation between total CLDQ scores in two evaluations was 0.97 and in all domains was >0.93. CLDQ was moderately correlated with the SF-36, 0.63 (total CLDQ vs. vitality, SF-36), 0.62 (CLDQ and mental health, SF-36), 0.62 (preoccupation, CLDQ, vs. General Health, SF-36), 0.59 (fatigue, CLDQ, vs. vitality, SF-36), 0.59 (activity, CLDQ, vs. vitality, SF-36), and 0.59 (fatigue, CLDQ, vs. mental health, SF-36). the highest scores were found in non-cirrhotic group. Child A patients had higher average scores than Child B and C groups in all domains, while patients with MELD <15 scored higher than patients with MELD >= 15.Conclusion CLDQ-BR was validated in Brazilian population and was appropriate for use in patients with liver disease of different etiologies and degrees of severity.en
dc.format.extent167-172
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofQuality of Life Research
dc.rightsAcesso restrito
dc.subjectQuality of lifeen
dc.subjectChronic liver diseaseen
dc.subjectValidationen
dc.subjectCLDQen
dc.subjectMELDen
dc.titleValidation of the Brazilian version of Chronic Liver Disease Questionnaireen
dc.typeArtigo
dc.rights.licensehttp://www.springer.com/open+access/authors+rights?SGWID=0-176704-12-683201-0
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.description.affiliationUniversidade Federal de São Paulo, Dept Psychiat, São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Surg Gastroenterol, São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Clin Gastroenterol, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Psychiat, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Surg Gastroenterol, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Clin Gastroenterol, São Paulo, Brazil
dc.identifier.doi10.1007/s11136-012-0138-2
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000315279300020


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record